Equator Therapeutics

📍 San Francisco, United States👥 7 employees💰 Last funded Dec 2020
Biotechnology Research🌐 equatortherapeutics.com
Website LinkedIn
Our drug will target mitochondria – the powerhouse of the cell – to generate heat. This approach has been proven to fully reverse obesity and type 2 diabetes in animals. However, therapeutic application for humans was impossible, because mitochondrial heat production could only be induced by highly artificial methods with side effects. This changed after our recent breakthrough discovery of the protein that mitochondria naturally use to generate heat. We have developed a unique high-throughput drug discovery platform to identify compounds that selectively activate this target protein, without side effects. For decades people have wanted a drug that burns calories like exercise does. We are realizing this dream at Equator Therapeutics.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
United Kingdom
1
Frequently asked questions
Who invested in Equator Therapeutics?
Equator Therapeutics has 2 investors on record on gritt.io.
When did Equator Therapeutics last raise funding?
The most recent investment in Equator Therapeutics recorded on gritt.io was in December 2020.
What industry is Equator Therapeutics in?
Equator Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Equator Therapeutics based?
Equator Therapeutics is headquartered in San Francisco, United States.